Literature DB >> 2849989

Structure-function studies of murine epidermal growth factor: expression and site-directed mutagenesis of epidermal growth factor gene.

P Ray1, F J Moy, G T Montelione, J F Liu, S A Narang, H A Scheraga, R Wu.   

Abstract

Wild-type murine epidermal growth factor (mEGF) and mutants with Leu47 replaced by serine and valine, respectively, have been produced by recombinant DNA methodology. A synthetic gene for mEGF was fused to the coding sequence for the signal peptide of the outer membrane protein A (ompA) of Escherichia coli in the secretion vector pIN-III-ompA3, and the recombinant plasmid was used to transform E. coli. Upon induction of gene expression, mEGF and the mutants was expressed and secreted into the periplasmic space. Purification of the wild-type Leu47-mEGF and the mutants was carried out by reversed-phase and anion-exchange high-performance liquid chromatography (HPLC). Amino acid analysis and Western blot analysis further confirmed the identities of the proteins. Specific activities for wild-type and mutant proteins were measured in both mEGF receptor binding and autophosphorylation assays. The recombinant mEGF has specific activities identical with that of mEGF purified from mouse submaxillary glands, while both mutants have reduced specific activities in both bioassays. The data demonstrate the importance of the highly conserved Leu47 residue in mEGF for full biological activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849989     DOI: 10.1021/bi00419a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Toward an automatic method for extracting cancer- and other disease-related point mutations from the biomedical literature.

Authors:  Emily Doughty; Attila Kertesz-Farkas; Olivier Bodenreider; Gary Thompson; Asa Adadey; Thomas Peterson; Maricel G Kann
Journal:  Bioinformatics       Date:  2010-12-07       Impact factor: 6.937

2.  Structure-function studies of mEGF: probing the type I beta-turn between residues 25 and 26.

Authors:  C C Lester; B Wang; R Wu; H A Scheraga
Journal:  J Protein Chem       Date:  1995-11

3.  Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation.

Authors:  C M Smas; L Chen; H S Sul
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

4.  Expression of functional human retinol-binding protein in Escherichia coli using a secretion vector.

Authors:  A Sivaprasadarao; J B Findlay
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

5.  Conformational characterization of a single-site mutant of murine epidermal growth factor (EGF) by 1H NMR provides evidence that leucine-47 is involved in the interactions with the EGF receptor.

Authors:  F J Moy; H A Scheraga; J F Liu; R Wu; G T Montelione
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  The heparin-binding domain of amphiregulin necessitates the precursor pro-region for growth factor secretion.

Authors:  B A Thorne; G D Plowman
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

7.  Development of an epidermal growth factor derivative with EGFR blocking activity.

Authors:  Clara Panosa; Francesc Tebar; Montserrat Ferrer-Batallé; Humphrey Fonge; Masaharu Seno; Raymond M Reilly; Anna Massaguer; Rafael De Llorens
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.